AiM Medical Robotics
Private Company
Total funding raised: $10.5M
Overview
AiM Medical Robotics is a private, pre-revenue medical device company founded in 2018, pioneering MRI-compatible robotic systems for neurosurgery. Its core technology platform integrates real-time MRI guidance with robotic precision to enable more accurate and efficient procedures for conditions like Parkinson's disease, epilepsy, and brain tumors. Led by a founder with deep academic expertise in MRI-guided robotics and a prominent neurosurgeon, the company is positioned to address a significant unmet need in the high-value neurosurgical robotics market, though it faces technical, regulatory, and competitive hurdles typical of early-stage device innovators.
Technology Platform
Portable, MRI-compatible surgical robotic system designed to integrate real-time MRI guidance for precision neurosurgical interventions in functional disorders and brain tumors.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
AiM operates in the competitive neurosurgical robotics and navigation market, competing with large players like Medtronic (StealthStation, Mazor), Zimmer Biomet, and Brainlab. Its key differentiation is direct MRI compatibility and portability, a niche not currently served by the major robotic systems which are not MRI-safe.